Rising Concerns towards Environmental Sustainability are the major Factors driving the Allergy Diagnostics Market Market

As stated by our extensive report, providing insights on product and procedure the global Allergy Diagnostics Market market accounted for USD 4,821.90 USD Million billion in 2021.

Increasing Exposure to indoor and outdoor air pollutants, allergens, and occupational exposure are the major risk factors causing chronic respiratory diseases. The rising allergic disorders among the urban population are higher than those living in rural areas due to the higher exposure to environmental pollutants in cities are major factors to fuel the Allergy Diagnostics Market Market.

According to World Health Organization (WHO), more than 85% of people living in cities areas are prone to air quality levels that exceed the WHO safety limits, although this is a global trend, its effects are more severe in the urban areas of developing countries. This is a major indicator for the growth of the Allergy Diagnostics Market Market, as air pollution from motor vehicles has been one of the major risk factors responsible for allergic diseases.

Epidemiological and toxicological research reveals a causal relationship between air pollution and the increased incidence of asthma, allergic rhinitis, and other allergic disorders. Research has demonstrated a significant rise in the incidence and exacerbation of asthma in urban locations with elevated PM 2.5 (particulate matter of size 2.5 micrometers or less), nitrogen dioxide, and ozone concentrations.

Global Allergy Diagnostics Market Market has been adversely affected in recent months owing to the outbreak of the pandemic, COVID-19, in December 2019. The outbreak has resulted in numerous countries imposing lockdowns and shutting down businesses except for essential services (allowed with minimum workforce). Several businesses have increased their focus on profitability and reduced their expenses in manufacturing, which is decreasing the demand for Allergy Diagnostics Market Market.

Asia Pacific is expected to grow at the fastest CAGR in the coming years owing to the high demand for allergy diagnostics in the healthcare sector.Additionally, this region has the most advanced healthcare facilities which are boosting the market to 10;Countries such as U.S. & Canada are considered to be the most developed countries in the field of allergy diagnostics technology. These are a few of the reasons is expected to grow in the coming years.

Developing economies like India, China, and the Middle East are considered to gain huge opportunities in the field of healthcare. North America held the largest share of the Allergy Diagnostics Market Market in 2021, followed by Europe and the Asia Pacific.In major parts of the world, the market is still growing owing to insufficient funds, lack of awareness, minimum availability of R&D facilities, underdeveloped IT infrastructure, and social constraints.

Major players of the {keyword} market such as Thermo Fisher Scientific Inc., (US), Siemens Healthineers (Germany), Danaher (US), Omega Diagnostics Group PLC (UK), bioMérieux SA (France), Romer Labs Division Holding (Austria), EUROIMMUN Medizinische Labordiagnostika AG (Germany), HollisterStier Allergy (US), NEOGEN Corporation (US), Eurofins Scientific (Luxembourg), Minaris Medical America, Inc. (US), Stallergenes Greer (UK), HOB Biotech Group Corp., Ltd. (China), HYCOR Biomedical (US), R-Biopharm AG (Germany), GmbH (Germany), ACON Laboratories, Inc. (US), Lincoln Diagnostics, Inc. (US), Astra Biotech GmbH (Germany), and Erba Group (UK)..